Oral Remibrutinib: New Hope for Chronic Urticaria Patients
Discover how oral remibrutinib, a recently FDA-approved treatment, offers fast and sustained relief for chronic spontaneous urticaria patients who failed antihistamines. Learn about the REMIX-1/-2 studies.